Literature DB >> 25548457

Clinicoinvestigational and demographic profile of children with thalassemia major.

Amita Trehan1, Nivedita Sharma1, Reena Das1, Deepak Bansal1, R K Marwaha1.   

Abstract

There are an estimated 200 million carriers of the β-thalassemia gene worldwide, 20 million being in India. The mean prevalence in India is 3.3 %. Objective To evaluate the clinico-investigational profile and the demographic characteristics of patients with thalassemia major (TM). Methods This was a retrospective analysis of the clinico-demographic profile at presentation of patients of TM diagnosed in the Paediatric Hematology Clinic of our hospital. Results The clinical profile of 964 patients of TM was analyzed. The mean age at presentation of untransfused children was 13.2 ± 9.7 months. Nearly 2/3(rd) children presented before 1 year of age. Almost 40 % had symptoms for 3 months prior to presentation. The manifestations at presentation included pallor and failure to thrive. About 40 % presented with severe anemia, with a hemoglobin of <5.0 gm/dl. A large number received blood transfusions prior to establishment of the diagnosis. Half of the families had ancestors who hailed originally from Pakistan. Approximately 50 % belonged to the Khatri/Arora castes. The parental literacy rate was about 90 %. Conclusions Thalassemia needs greater public awareness and prevention strategies in our country. Some communities are at high risk as compared to others. Education programs and compulsory antenatal screening appear to be the order of the day.

Entities:  

Keywords:  Age; Blood transfusion; Caste; Education; Literacy; Thalassemia major

Year:  2014        PMID: 25548457      PMCID: PMC4275533          DOI: 10.1007/s12288-014-0388-y

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  19 in total

1.  Pattern of hemoglobinopathies in western Maharashtra.

Authors:  S S Ambekar; M A Phadke; G D Mokashi; M P Bankar; V A Khedkar; V Venkat; D G Basutkar
Journal:  Indian Pediatr       Date:  2001-05       Impact factor: 1.411

2.  Spectrum of hemoglobinopathies in Orissa, India.

Authors:  Guru Prasad Chhotray; Bisnu Prasad Dash; Manoranjan Ranjit
Journal:  Hemoglobin       Date:  2004-05       Impact factor: 0.849

Review 3.  Thalassemia syndromes.

Authors:  Asha Shah
Journal:  Indian J Med Sci       Date:  2004-10

Review 4.  Beta-thalassemia.

Authors:  Deborah Rund; Eliezer Rachmilewitz
Journal:  N Engl J Med       Date:  2005-09-15       Impact factor: 91.245

5.  Beta-thalassaemia trait in the Punjab (North India)

Authors:  S Dash
Journal:  Br J Haematol       Date:  1985-09       Impact factor: 6.998

6.  Growth impairment in beta-thalassemia major: the role of trace element deficiency and other potential factors.

Authors:  Peyman Eshghi; Samin Alavi; Saeed Ghavami; Armin Rashidi
Journal:  J Pediatr Hematol Oncol       Date:  2007-01       Impact factor: 1.289

Review 7.  Growth of children with beta-thalassemia major.

Authors:  Louis Ck Low
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

8.  Thalassaemia in Vanuatu, south-west Pacific: frequency and haematological phenotypes of young children.

Authors:  M Ganczakowski; D K Bowden; K Maitland; T N Williams; D O'Shaughnessy; J Viji; A Lucassen; J B Clegg; D J Weatherall
Journal:  Br J Haematol       Date:  1995-03       Impact factor: 6.998

9.  Hematological status of beta-thalassemics in Madras.

Authors:  N Mohan; R Sarkar
Journal:  Indian J Pediatr       Date:  1994 May-Jun       Impact factor: 1.967

Review 10.  Past, present & future scenario of thalassaemic care & control in India.

Authors:  Ishwar C Verma; Renu Saxena; Sudha Kohli
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

View more
  6 in total

1.  Socio-demographic Profile and Economic Burden of Treatment of Transfusion Dependent Thalassemia.

Authors:  Amita Moirangthem; Shubha R Phadke
Journal:  Indian J Pediatr       Date:  2017-11-09       Impact factor: 1.967

2.  Time to Start Delivering Iron Chelation Therapy in Newly Diagnosed Severe β-Thalassemia.

Authors:  Susi Susanah; Ponpon S Idjradinata; Nur M Sari; Lulu E Rakhmilla; Yunia Sribudiani; Jessica O Trisaputra; Octawyana Moestopo
Journal:  Biomed Res Int       Date:  2020-12-13       Impact factor: 3.411

3.  Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine.

Authors:  Priya Hariharan; Manju Gorivale; Pratibha Sawant; Pallavi Mehta; Anita Nadkarni
Journal:  Sci Rep       Date:  2021-10-22       Impact factor: 4.379

4.  Thalassemia, extramedullary hematopoiesis, and spinal cord compression: A case report.

Authors:  Syed Sarmad Bukhari; Muhammad Junaid; Mamoon Ur Rashid
Journal:  Surg Neurol Int       Date:  2016-03-02

5.  Association of frequency of hereditary hemochromatosis (HFE) gene mutations (H63D and C282Y) with iron overload in beta-thalassemia major patients in Pakistan.

Authors:  Yasir Sharif; Saba Irshad; Anam Tariq; Sana Rasheed; Muhammad H Tariq
Journal:  Saudi Med J       Date:  2019-09       Impact factor: 1.484

6.  Malnutrition, Its Attributes, and Impact on Quality of Life: An Epidemiological Study among β-Thalassemia Major Children.

Authors:  Bijit Biswas; Narendra Nath Naskar; Keya Basu; Aparajita Dasgupta; Rivu Basu; Bobby Paul
Journal:  Korean J Fam Med       Date:  2020-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.